Nov 22, 2022 10:01 AM (GMT+8) · EqualOcean
UB biotechnology (Zhejiang) Co., LTD. (Chinese:泛肽生物科技(浙江)有限公司) recently announced its completion of a Series A round of financing worth tens of millions of CNY. This round was invested by Yuanbio Venture Capital (Chinese:元生创投), with Potential Capital (Chinese:取势资本) acting as the exclusive financial advisor. The funds will be primarily used for further R&D and market expansion in the flow cytometry technology platform, providing comprehensive solutions for accurate assessment of immune function for clinical patients.